بدائل البحث:
largest decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث)
values decrease » values increased (توسيع البحث)
parp decrease » a decrease (توسيع البحث), pa decreased (توسيع البحث), step decrease (توسيع البحث)
_ largest » _ large (توسيع البحث)
largest decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث)
values decrease » values increased (توسيع البحث)
parp decrease » a decrease (توسيع البحث), pa decreased (توسيع البحث), step decrease (توسيع البحث)
_ largest » _ large (توسيع البحث)
-
1
-
2
ROC curve and AUC value of all models.
منشور في 2024"…As for Specificity (82.94%) and ROC-AUC (82.13%), the Multilayer Perceptron with SGD optimizer obtained the highest scores. …"
-
3
Inotodiol decreases clone formation in HCC cells.
منشور في 2025"…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …"
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Statistical analysis of the AUC measurement.
منشور في 2025"…<p>Analysis indicated that INSv application significantly changed spontaneous calcium activity (IAsp <i>p</i>-value: 0.1290, INSv <i>p</i>-value: 0.0002). The mean AUC decreased in both samples.…"
-
14
-
15
-
16
PARP9 knockdown promotes apoptosis and DNA damage.
منشور في 2024"…(E) DNA damage in GC cells significantly increased post-PARP9 knockdown as determined by comet assay. (F) The anti-DNA damage capacity of GC cells decreased markedly following reduction of PARP9 expression. …"
-
17
-
18
-
19
-
20
Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf
منشور في 2025"…In this work, we developed noninvasive imagingbased measurements of spatial and longitudinal heterogeneity in a retrospective analysis of a phase 2 non-randomized study of germline BRCA1/BRCA2 mutated (gBRCAm) ovarian cancer patients treated with combination of PARP inhibitors (PARPi) and immune checkpoint inhibitors (ICIs).…"